Literature DB >> 25011396

Vascular cognitive impairment in dementia.

Christopher D Etherton-Beer1.   

Abstract

Vascular risk factors and cerebrovascular disease are common causes of dementia. Shared risk factors for vascular dementia and Alzheimer's disease, as well as frequent coexistence of these pathologies in cognitively impaired older people, suggests convergence of the aetiology, prevention and management of the commonest dementias affecting older people. In light of this understanding, the cognitive impairment associated with cerebrovascular disease is an increasingly important and recognised area of the medicine of older people. Although the incidence of cerebrovascular events is declining in many populations, the overall burden associated with brain vascular disease will continue to increase associated with population ageing. A spectrum of cognitive disorders related to cerebrovascular disease is now recognised. Cerebrovascular disease in older people is associated with specific clinical and imaging findings. Although prevention remains the cornerstone of management, the diagnosis of brain vascular disease is important because of the potential to improve clinical outcomes through clear diagnosis, enhanced control of risk factors, lifestyle interventions and secondary prevention. Specific pharmacological intervention may also be indicated for some patients with cognitive impairment and cerebrovascular disease. However the evidence base to guide intervention remains relatively sparse.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Brain ischaemia; Cerebral infarction; Cerebrovascular disorders; Dementia; Vascular

Mesh:

Substances:

Year:  2014        PMID: 25011396     DOI: 10.1016/j.maturitas.2014.06.004

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  5 in total

1.  Computed tomography perfusion imaging may predict cognitive impairment in patients with first-time anterior circulation transient ischemic attack.

Authors:  Jun Wang; Yunming Li; Bo Zheng; Jian Wang; Zhiqiang Wang; Dan Duan; Yuxia Li; Qingsong Wang
Journal:  Int J Cardiovasc Imaging       Date:  2015-12-31       Impact factor: 2.357

2.  CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses.

Authors:  Dan-Dan Liu; Xia Yuan; Shi-Feng Chu; Chen Chen; Qian Ren; Piao Luo; Mei-Yu Lin; Sha-Sha Wang; Tian-Bi Zhu; Qi-di Ai; Ying-da Zang; Dong-Ming Zhang; Xin He; Zhi-Hua Huang; Hong-Shuo Sun; Zhong-Ping Feng; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

3.  Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo.

Authors:  Takahiko Chimura; Thomas Launey; Nobuaki Yoshida
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 4.  Regulatory microRNAs and vascular cognitive impairment and dementia.

Authors:  Jing Zhang; Ping Sun; Chao Zhou; Xuejing Zhang; Feifei Ma; Yang Xu; Milton H Hamblin; Ke-Jie Yin
Journal:  CNS Neurosci Ther       Date:  2020-12       Impact factor: 5.243

5.  Meta-Analysis on the Efficacy and Safety of Hyperbaric Oxygen as Adjunctive Therapy for Vascular Dementia.

Authors:  Qiang You; Lan Li; Su-Qin Xiong; Yu-Fen Yan; Dan Li; Na-Na Yan; Hong-Ping Chen; You-Ping Liu
Journal:  Front Aging Neurosci       Date:  2019-04-17       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.